FDA Drug recall D-1165-2022
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc
- FDA Drug
- Class I
- terminated
- Published 2022-07-06
On 2022-07-06 the FDA classified a Class I recall of SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc by Green Pharmaceuticals, citing microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1165-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-06-09 |
| Published | 2022-07-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Green Pharmaceuticals |
| Distribution | US |
Product
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Reason
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Identifiers
| upc | 769682291013 |
|---|---|
| code_info | Lot #: 2373/21222 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1165-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.